FundingWatcher
Home / Startups / Top biotech startups / Biotech startups in Boston, Massachusetts

Biotech startups in Boston, Massachusetts

Updated 16 Nov 2026

Reset
Biotech startups in Boston, Massachusetts
One-time CSV
  • 211 funded companies, 186 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech~boston-massachusetts.csv211 rows × 18 columns
CompanyCityLast roundAmountDate
Ratio TherapeuticsBostonSeries C$70.0M2026-07-31
NeurableBostonSeries A$35.0M2025-12-19
VideaHealthBostonSeries B$40.0M2025-01-28
Ascidian TherapeuticsBostonSeries A$40.0M2023-11-08
AsimovBostonSeries B$175.0M2023-01-05
EmulateBostonSeries F$47.1M2024-03-20
Precede BiosciencesBostonSeries B$63.5M2026-01-12
Superluminal MedicinesBostonSeries B$65.5M2026-09-03

8 rows of the CSV in 5 of its 18 columns.

211
Startups
$11.7B
Total raised
42
Funded in the last 12 months
$1.5B
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

22 of 211
22 rows
Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
Delix Therapeutics Delix Therapeutics develops psychoplastogen therapies that promote neuroplasticity. Biotech Series C $100.0M 2026-11-09 $244.1M Gaingels, RA Capital Management, Dolby Family Ventures +2 11 to 50 2019
INIA Biosciences INIA Biosciences develops non-invasive, home-administered medical devices to manage chronic inflammatory diseases. Biotech Seed $1.5M 2026-09-08 $1.5M MassChallenge, MedTech Innovator 1 to 10 2020
Superluminal Medicines Superluminal Medicines develops small-molecule therapeutics by combining AI, biology, and chemistry. Artificial intelligence Series B $65.5M 2026-09-03 $223.5M Insight Partners, RA Capital Management, NVentures 11 to 50 2022
Dash Bio Dash Bio develops automated laboratory workflows and software to support drug development through bioanalysis services. Artificial intelligence Series A $30.0M 2026-08-03 $47.5M Freestyle Capital, Swift Ventures, LifeX Ventures +1 11 to 50 2024
Ratio Therapeutics Ratio Therapeutics develops radiopharmaceuticals to treat solid tumors in clinical trials. Biotech Series C $70.0M 2026-07-31 $160.0M Bristol-Myers Squibb, The Pags Group, Schusterman Family Investments 11 to 50 2021
Cerevance Cerevance develops novel therapeutics for neurological diseases. Biotech Series C $20.0M 2026-05-12 $209.5M Google Ventures, Casdin Capital, Foresite Capital +1 51 to 100 2016
Third Arc Bio Third Arc Bio develops multifunctional antibodies for inflammatory and immunology diseases. Biotech Series A $52.0M 2026-02-04 $217.0M T. Rowe Price, Cormorant Asset Management, Foresite Capital +1 11 to 50 2022
Precede Biosciences Precede Biosciences develops blood-based tests that reveal disease-defining transcriptional biology. Biotech Series B $63.5M 2026-01-12 $140.5M Bristol-Myers Squibb, Lilly Asia Ventures, 5AM Ventures +2 11 to 50 2005
Neurable Neurable develops AI tools for translating brain signals and brain-computer interface technology. Artificial intelligence Series A $35.0M 2025-12-19 $57.3M National Science Foundation, Global Brain Corporation, Metaplanet +1 11 to 50 2015
Biometry Biometry develops diagnostic tools for patients with chronic respiratory conditions. Artificial intelligence Seed $2.2M 2025-12-19 $7.8M MassChallenge, Elevate Ventures, Sidecar Angels +1 11 to 50 2013
AI Proteins AI Proteins designs and engineers miniprotein therapeutics using artificial intelligence. Artificial intelligence Series A $42.5M 2025-11-19 $80.4M Intel Ignite, Lightchain Capital, Cobro Ventures 11 to 50 2021
Elucid Elucid applies AI to medical images to support precision medicine for cardiovascular disease. Biotech Series D $36.5M 2025-10-22 $166.2M National Science Foundation, Sand Hill Angels, IAG Capital Partners +1 101 to 250 2013
Folia Health Folia Health is a platform that securely captures and shares users' health and symptom data. Biotech Series A $10.5M 2025-10-01 $17.4M MassChallenge, Social Starts, Bantam Group +2 11 to 50 2016
VideaHealth VideaHealth offers dentistAI software that automatically detects pathologies in dental imaging to help dentists avoid missed diagnoses. Biotech Series B $40.0M 2025-01-28 $66.5M Spark Capital, Zetta Venture Partners, Pillar VC +2 51 to 100 2018
Cardurion Pharmaceuticals Cardurion Pharmaceuticals develops cardiovascular therapeutics for heart failure and related diseases. Biotech Series B $260.0M 2024-07-16 $603.1M New Enterprise Associates, Google Ventures, Fidelity +1 11 to 50 2017
Adaptilens Adaptilens develops an accommodating intraocular lens for cataract patients. Biotech Series A $17.5M 2024-04-29 $19.1M MassChallenge, Pillar VC, Perceptive Advisors +2 1 to 10 2019
Emulate Emulate creates advanced in vitro models to study how diseases, medicines, and chemicals affect human health. Biotech Series F $47.1M 2024-03-20 $271.3M Alumni Ventures, Qiming Venture Partners, National Institutes of Health 51 to 100 2013
Alys Pharmaceuticals Alys Pharmaceuticals develops immuno-dermatology treatments as a biopharmaceutical company. Biotech Seed $100.0M 2024-02-12 $100.0M Medicxi 11 to 50 2024
Ascidian Therapeutics Ascidian Therapeutics is a biotechnology company focused on medical and clinical gene therapy. Biotech Series A $40.0M 2023-11-08 $90.0M Apple Tree Partners 11 to 50 2020
Asimov Asimov uses artificial intelligence to build tools for designing and manufacturing therapeutics. Artificial intelligence Series B $175.0M 2023-01-05 $205.0M Andreessen Horowitz, DCVC, Fidelity +2 101 to 250 2017
Biofourmis Unicorn Biofourmis develops healthcare technology platforms that monitor patients at home. Artificial intelligence Series D $20.0M 2022-07-27 $463.6M Sequoia Capital, Intel Capital, Peak XV Partners +1 251 to 500 2015
Orbita Orbita sells voice-first and conversational AI software that helps patients engage with digital healthcare. Artificial intelligence Series A $9.0M 2020-05-27 $16.5M MassChallenge, nvp capital, Cultivation Capital +2 11 to 50 2015

Table 1. Biotech startups in Boston, Massachusetts: the 22 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 211.

Largest rounds

Last 12 months
10 rows
# Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
1 Delix Therapeutics Delix Therapeutics develops psychoplastogen therapies that promote neuroplasticity. Biotech Series C $100.0M 2026-11-09 $244.1M Gaingels, RA Capital Management, Dolby Family Ventures +2 11 to 50 2019
2 Ratio Therapeutics Ratio Therapeutics develops radiopharmaceuticals to treat solid tumors in clinical trials. Biotech Series C $70.0M 2026-07-31 $160.0M Bristol-Myers Squibb, The Pags Group, Schusterman Family Investments 11 to 50 2021
3 Superluminal Medicines Superluminal Medicines develops small-molecule therapeutics by combining AI, biology, and chemistry. Artificial intelligence Series B $65.5M 2026-09-03 $223.5M Insight Partners, RA Capital Management, NVentures 11 to 50 2022
4 Precede Biosciences Precede Biosciences develops blood-based tests that reveal disease-defining transcriptional biology. Biotech Series B $63.5M 2026-01-12 $140.5M Bristol-Myers Squibb, Lilly Asia Ventures, 5AM Ventures +2 11 to 50 2005
5 Third Arc Bio Third Arc Bio develops multifunctional antibodies for inflammatory and immunology diseases. Biotech Series A $52.0M 2026-02-04 $217.0M T. Rowe Price, Cormorant Asset Management, Foresite Capital +1 11 to 50 2022
6 AI Proteins AI Proteins designs and engineers miniprotein therapeutics using artificial intelligence. Artificial intelligence Series A $42.5M 2025-11-19 $80.4M Intel Ignite, Lightchain Capital, Cobro Ventures 11 to 50 2021
7 Neurable Neurable develops AI tools for translating brain signals and brain-computer interface technology. Artificial intelligence Series A $35.0M 2025-12-19 $57.3M National Science Foundation, Global Brain Corporation, Metaplanet +1 11 to 50 2015
8 Dash Bio Dash Bio develops automated laboratory workflows and software to support drug development through bioanalysis services. Artificial intelligence Series A $30.0M 2026-08-03 $47.5M Freestyle Capital, Swift Ventures, LifeX Ventures +1 11 to 50 2024
9 Cerevance Cerevance develops novel therapeutics for neurological diseases. Biotech Series C $20.0M 2026-05-12 $209.5M Google Ventures, Casdin Capital, Foresite Capital +1 51 to 100 2016
10 Biometry Biometry develops diagnostic tools for patients with chronic respiratory conditions. Artificial intelligence Seed $2.2M 2025-12-19 $7.8M MassChallenge, Elevate Ventures, Sidecar Angels +1 11 to 50 2013

Table 2. Biotech startups in Boston, Massachusetts: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 MassChallenge Startup accelerator Boston, United States 5 2% 2 INIA Biosciences, Biometry
2 National Science Foundation Entrepreneurship program Alexandria, United States 4 2% 1 Neurable
3 Pillar VC Venture capital firm Boston, United States 3 1%
4 Fidelity Investment bank Boston, United States 3 1%
5 Insight Partners Private equity firm New York, United States 3 1% 1 Superluminal Medicines
6 Bristol-Myers Squibb Venture capital firm New York, United States 2 1% 2 Ratio Therapeutics, Precede Biosciences
7 Qiming Venture Partners Venture capital firm Shanghai, China 2 1%
8 Alumni Ventures Angel group Manchester, United States 2 1%
9 Illumina Ventures Corporate venture arm Foster City, United States 2 1% 1 Precede Biosciences
10 RA Capital Management Startup incubator Boston, United States 2 1% 2 Delix Therapeutics, Superluminal Medicines
11 Foresite Capital Private equity firm San Francisco, United States 2 1% 2 Cerevance, Third Arc Bio
12 Sequoia Capital Venture capital firm Menlo Park, United States 2 1%
13 LaunchPad Venture Angel group Newton, United States 2 1%
14 Joyance Partners Venture capital firm San Francisco, United States 2 1%
15 Google Ventures Corporate venture arm San Francisco, United States 2 1% 1 Cerevance

Table 3. Biotech startups in Boston, Massachusetts: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 175 83% $10.4B
Software 42 20% $2.3B
Artificial intelligence 27 13% $1.8B
Hardware 12 6% $224.8M
Commerce 2 1% $72.0M
Energy 2 1% $7.8M
Education 1 0% $30.0M
Cybersecurity 1 0%
Fintech 1 0%

Table 4. Biotech startups in Boston, Massachusetts by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Pre-seed 22 10% $600K
Seed 73 35% $2.2M
Series A 57 27% $34.0M
Series B 40 19% $50.0M
Series C 14 7% $70.0M
Series D+ 5 2% $47.1M

Table 5. Biotech startups in Boston, Massachusetts by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 2 5% $111.5M
October 2026 3 7% $189.0M
September 2026 5 12% $317.3M
August 2026 3 7% $80.0M
July 2026 2 5% $70.0M
June 2026 4 10% $52.9M
May 2026 2 5% $22.0M
April 2026 4 10% $99.3M
March 2026 2 5% $3.5M
February 2026 1 2% $52.0M
January 2026 7 17% $255.5M
December 2025 3 7% $57.2M
November 2025 4 10% $199.7M

Table 6. Biotech startups in Boston, Massachusetts: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 35 17% $1.3B
2025 37 18% $947.1M
2024 29 14% $1.4B
2023 16 8% $524.6M
2022 19 9% $488.4M
2021 16 8% $536.2M

Table 7. Biotech startups in Boston, Massachusetts by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 44 21%
2020 to 2022 49 23%
2015 to 2019 70 33%
2010 to 2014 29 14%
Before 2010 17 8%

Table 8. Biotech startups in Boston, Massachusetts by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 80 39%
11 to 50 94 46%
51 to 100 17 8%
101 to 250 11 5%
251 to 500 2 1%
501 to 1,000 1 0%

Table 9. Biotech startups in Boston, Massachusetts by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in Boston, Massachusetts are on the list?
211, in the file dated 16 November 2026. 42 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 211 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups in Boston, Massachusetts: 211 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech startups in Boston, Massachusetts by funding stage

Other sectors in Boston

Biotech startups elsewhere

Cite: FundingWatcher, 211 funded biotech companies in Boston, Massachusetts, 16 November 2026. https://fundingwatcher.com/startups/biotech/boston-massachusetts/